SINGAPORE, October 6 (Reuters): China is in talks to have its locally-produced COVID-19 vaccines assessed by the World Health Organization, as a step toward making them available for international use, a W
New Delhi, October 4 (IANS): Union Health Minister Harsh Vardhan said on Sunday that the Centre is working on plans to procure 400-500 million doses of Covid-19 vaccine, which will be administered to up to 25 c
New Delhi, October 4 (PTI): The Centre estimates to receive and utilise 40-50 crore doses of COVID-19 vaccine covering 20-25 crore people by July next year and it is preparing a format for the states to submit
London, October 4 (IANS): The COVID-19 vaccine developed by scientists at the Oxford University, which is advanced stages of the trial, could be rolled out in as little as three months in the UK, a report said.
October 3 (Reuters) - A mass roll-out of a COVID-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists.
Scientists working on the Oxford vacci
MOSCOW, September 29 (Reuters): Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied glo
New Delhi, September 29 (IANS) A further collaboration among the Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, Gavi and the Bill and Melinda Gates Foundation will
Adar Poonawalla: Will Govt have 80,000 crores available over the next one year?
New Delhi, September 26 (IANS): Rs 80,000 crore will be the cost of vaccinating everyone in India with the Covid-19 vaccine whe
CHICAGO, September 23 (Reuters): Johnson & Johnson on Wednesday kicked off a final 60,000-person trial of a single-shot COVID-19 vaccine that potentially would simplify distribution of millions of dose
New Delh, September 19 (PTI): The Phase 3 human clinical trial of the COVID-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon Gener
SINGAPORE, September 17 (Reuters): The World Health Organisation said that more than 170 countries had joined its global plan to distribute vaccines fairly around the world, but cautioned that a race to de
GENEVA, September 4 (Reuters): WHO Director-General Tedros Adhanom Ghebreyesus called for countries around the world to join forces to tackle the coronavirus on Friday, saying that "vaccine nationalis
GENEVA, September 4 (Reuters): The World Health Organization does not expect widespread vaccinations against COVID-19 until the middle of next year, a spokeswoman said on Friday, stressing the importance o
New Delhi, September 4 (PTI): The COVID-19 vaccine, Sputnik V, approved by Russia last month, has been shown to elicit antibody response with no serious adverse events in small human trials, according to prelim
New York, September 1 (IANS): The Covid-19 vaccine candidate developed by Oxford University in partnership with the UK-based global biopharmaceutical company AstraZeneca has reached Phase-3 trial in the US.
Mysuru (Karnataka), August 30 (IANS): Clinical trial of the Covishield vaccine, developed by the University of Oxford, began at the JSS Hospital in Mysuru, an official said on Sunday.
"The clinical tria
London, August 28 (IANS): The British government on Friday proposed measures to give emergency approval to a safe and effective Covid-19 vaccine and train a large number of people in administering it in order t
BRUSSELS, August 27 (Reuters): The European Commission has made a 336 million euros ($396 million) downpayment to British drug maker AstraZeneca to secure at least 300 million doses of its potential COVID-
MOSCOW, August 20 (Reuters): Mass testing of Russia's first potential COVID-19 vaccine to get domestic regulatory approval will involve more than 40,000 people and will be overseen by a foreign researc
Reuters
Rich countries should not hoard a coronavirus vaccine and should only give pandemic-related bailouts to companies committed to protecting the environment, helping the most needy and the 'common g